Drug Company eBay auctions you should keep an eye on:
SD, Vernal, South Dakota, RPPC, Centre Street Scene, Vernal Drug Company
 | .99 End Date: Friday Sep-14-2012 16:28:57 PDT Buy It Now for only: .99 Buy it Now | Add to watch list |
Old Antique Cobalt Blue Owl Drug Company 3 Sided Apothecary Poison Bottle
 | .95 (0 Bids) End Date: Monday Aug-20-2012 18:00:17 PDT Bid now | Add to watch list |
& electrical. Must be able to pass a drug and criminal experience investigation. Must be clean cut.
Pay
.). Follows company safety policies and procedures and encourages other associates to do the same.
- Install
Epson Stylus NX420 Color Ink Jet All-in-One (C11CA80201)
Diaper Rash Ointment 6 ozDrug Company on eBay:
1913 PHOTO POSTCARD ARTESIAN HOTEL Sulphur Oklahoma OK McGinnis Drug Co
 | .35 End Date: Thursday Sep-13-2012 18:25:40 PDT Buy It Now for only: .35 Buy it Now | Add to watch list |
Lovely Art Nouveau silver covered prayerbook HM Birmingham Boots Pure Drug Co.
 | .69 (4 Bids) End Date: Wednesday Aug-15-2012 11:19:33 PDT Bid now | Add to watch list |
Vintage Rexall Drug Co. Rex-Ray Infra-Red Dark Amber Heat Lamp Wall Mount in Box
 | .99 (0 Bids) End Date: Wednesday Aug-15-2012 5:41:30 PDT Bid now | Add to watch list |
Check out these Drug Company images:
KATZ DRUG COMPANY SIGNAGE 1980s
Image by roberthuffstutter
Fading ad for Greenville Ice Cream Co
Image by markemark4
A fading advertisement for Italian Vanilla ice cream by Greenville Ice Cream Company. The advertisement is located on the side of the old Taylors Drug Company location.
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT
Image by Butte-Silver Bow Public Library
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT, image taken from p 38 of Cartoons and Caricatures of Men in Montana (1907) by E.A. Thomson
Cartoons and Caricatures
of Men in Montana p 38
On cover: Just For Fun
Unique ID: mze-cart1907
Type: Book
Contributors: Artists: John C. Terry, F.P. Ellis, Alan L. Lovey, and A.H. Dutton
Date Digital: January 2011
Date Original: 1907
Source: Butte Digital Image Project at Montana Memory Project (read the book)
Library: Butte-Silver Bow Public Library in Butte, Montana, USA.
Rights Info: Public Domain. Not in Copyright. Please see Montana Memory project Copyright statement and Conditions of Use
(for more information, click here). Some rights reserved.
Attribution-Noncommercial-No Derivative Works.
More information about the href="http://cdm103401.cdmhost.com/cdm4/about.php" rel="nofollow">Montana Memory Project: Montana's Digital
Library and Archives.
More information about the Butte-Silver Bow Public Library.
Search the Butte-Silver Bow Public Library Catalog.
Event on 2012-08-11 08:30:00
Key Themes Discussed at this Summit:
• Where does India stand in the current global clinical trials market and how to take advantage of the same? How can you take advantage of the global market for clinical trials?
• Discovering technologies and strategies for successful clinical trial management
• Strategies in conducting successful interventional oncology trials in India
• Setting up clinical trial research hub & techniques for applying risk management principles.
• Discovering global opportunities in clinical trial and selecting the right partners to penetrate successfully into the Indian market
• Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India to develop appropriate clinical studies
• Avoiding potential pitfalls of trials agreement
• Regulatory review at the Drugs Controller General of India (DCGI) and Central
Drugs Standard Control Organization (CDSCO): science, quality, and speed
• Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
• Effectively managing cold chain and logistics in clinical trials
• Optimising clinical trials operation effectiveness and ROI through strategic site,patient, data and risk management in the regulated markets
• What are the issues with off-shoring trials to countries such as India & South Asia? – Solutions?
• Motivating and managing clinical project teams to improve timeline and progress
• Exploring the efficacy and safety of new interventions in clinical trials
• Drawing and retaining clinical talent pool to minimise turnover in clinical studies
• Next generation of clinical trials – How big will the market be?
Key Speakers :
• Arun Bhatt, President, Clininvent Research
• Bhaswat S. Chakraborty, Senior Vice President, Research and Development, Cadila
• Girish S. Gudi, Vice President, Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals
• Ammar Raza, Associate Director- Medical Affairs, AstraZeneca
• Viraj Rajadhyaksha, Associate Director - Medical Liaison, Sanofi-Aventis
• Arani Chatterjee, Vice President, Clinical Research, Panacea Biotec
• Rohit Arora, Deputy Director, Sanofi Pasteur
• Prashant Bodhe, Head Regulatory Affairs & Vice President Operations, DMRI
• Subashri Shivkumar, Hub Unit Director-Regional Clinical Operations, Bristol-Myers Squibb
• Chirag Trivedi, Head - Medical Affaris Clinical Operations, Sanofi-Aventis
• Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
• Farzana Lakdavala, Medical Advisor, Project Manager Clinical Research, Wockhardt
• Murtuza S. Bughediwala, General Manager, Clinical Operations & Business Development, Clininvent Research
• Poonam Sule, Senior Manager - Clinical Research (International), Wockhardt
• Ashish Gawde, Senior Manager- Clinical Research, BAYER
• Jeroze Dalal, General Manager Clinical Operations, GlaxoSmithKline
Plus many more
Who Should Attend:
Vice Presidents, Directors Heads & Managers of:
• Clinical Research & Development
• Clinical Research Services
• Clinical Operations
• Clinical Data Management
• Clinical IT
• Clinical Trials
• Medical Affairs
• Regulatory Affairs
• Compliance
• Quality control / Assurance/GCP
• Clinical Study Design
• Safety Surveillance
• Subject Recruitment
• E-Clinical Systems
Target Audience – Industry:
• Pharmaceutical Organisations
• Generic pharmaceutical companies
• Contract Research Organisations
• Patient Recruitment Companies
• Government- Department of Health
• Non-profit organisations/ Association
• Academics
• Consultants
Why Should You Attend?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Ordering Delegate Pass – Register Now
Ordering is simple! You can simply email or call and book your seats on
TEL: +91 (44) 23770517 . Email – delegate@virtueinsight.com
For this one day conference, conference fee is 05,000 INR + tax per person
Should you have any queries, please feel free to write to us pradeep@virtueinsight.com, pradeepvic@yahoo.com
at Grand Intercontinental
Mumbai
Mumbai, India
Event on 2012-08-25 00:00:00
The NACDS Pharmacy & Technology Conference is the largest industry gathering of retail pharmacy executives from Drug, Food and Mass and their supplier counterparts. It brings together nearly 300 manufacturers of pharmacy products and services and decision-makers from more than 130 retail companies comprised of chain drug stores, supermarkets, and mass merchants who collectively represent over 80,000 retail outlets and more than 0 billion in annual sales for prescription drugs, OTC, and home healthcare.
The Pharmacy & Technology Conference offers equal parts business meeting and exhibition opportunities, and the most expansive and timely selection of educational programming in the industry. Topics presented cover the most critical issues facing chain pharmacy today. If you buy or sell pharmaceutical products, services, or technology solutions or make decisions about pharmacy operations, you can’t afford to miss this Conference!
About NACDS
The National Association of Chain Drug Stores (NACDS) represents traditional drug stores, supermarkets, and mass merchants with pharmacies – from regional chains with four stores to national companies. Chains operate more than 40,000 pharmacies and employ more than 3.5 million employees, including 130,000 pharmacists. They fill over 2.6 billion prescriptions annually, which is more than 72 percent of annual prescriptions in the United States. The total economic impact of all retail stores with pharmacies transcends their 0 billion in annual sales. Every spent in these stores creates a ripple effect of .81 in other industries, for a total economic impact of .76 trillion, equal to 12 percent of GDP. For more information about NACDS, visit www.NACDS.org.
at Colorado Convention Center
700 14th Street
Denver, United States
Discover The Truth About Cancer That 94% Of Doctors Don't Even Know Exist, And The Greedy Drug Companies Hope You Never Find Out...
How To Beat A Drug Test. We Give Our Clients Full Service Support We Have Over A 99% Success Rate. Its A Top Seller. Get Involved Today To Watch Your Sales Increase. Over 200,000 Peple Tested Daily Get In The Game Today. You Will Makes Sales, Start Today!
Handbook of Psychiatric Drug Therapy
Pharma Industries, The Truth About Drug Companies (Heal Me For A Dollar)
Non-Drug Treatments for ADHD: New Options for Kids, Adults, and CliniciansAs FTRNation.com continues to celebrate the official launch of Freethinking Renegade Awareness Month they are excited to see the nation take responsibility for life matters that cause stress. Last week the public was encouraged to take part in a 3 part blog/video series on obliterating career stress. This week the focus is on financial stress.
It?s logical to conclude that financial stress is most significantly tied to career stress (or Job Security), after all, there is very little money if one is unemployed.
Looking at recent statistics According to Cato Institute, The American Welfare State, April 11, 2012,: Forty-six million Americans live in poverty. That accounts for 15.1 percent of Americans which is the highest level in nearly a decade. Since Obama took office, federal expenditures on welfare have increased by 41 percent, more than $ 193 billion per year.
In another release, the jobless rate in the Euro area reached it?s highest on records dating to 1995 as the debt crisis and deepening economic slump prompted companies to cut jobs.
Unemployment in the economy of the 17 nations using the Euro reached a revised 11.2 percent in May and held at that level in June.
Drought, foreclosures, housing price declines are also at an all-time high as are the cost of goods and standard living expenses as well. We are all making less money or none at all and are burdened by the increasing cost of living.
This is so far reaching that our children are being impacted. Now we have learned that 3 out of every 10 New Yorkers between the ages of 25 and 30 are living with their parents. Inceptia reported that students are being forced to reduce their course load to deal with stressors, including the cost of education and need to repay loans.
We are all impacted one way or another by these horrific numbers and yet ? consumer spending is steady. Yes, people are saving more ? but they also need to spend less.
Happiness should not come at a price. We need to build awareness of this and stop being a part of the statistical nightmares researchers and study groups continue to flood us with.
Freethinking Renegade Awareness Month, challenges the world to stop for just a few days and take inventory of what is really happening in our lives. We need to bring awareness to how we perceive our personal status in life and business, and why. We need to ask ourselves what we are doing to create our problems, what we are not doing to fix them, how we can break our intrinsically bad habits in order to reprogram ourselves for more euphoric levels of happiness and success.
Founder of FTRNation.com, Brian Grasso says ?We all have it in us to live a life of ecstasy; a life of truly profound bliss ? as long as we are aware.?
If we do not build our awareness from a systemic level (looking at our hearts, minds, body and SOUL as a collective unit ? where one feeds the other) we will not and can not get there. Simply ?acting? aware as opposed to digging deep inside and being aware from a core level would be the equivalent to treating a symptom of a bigger problem with pharmaceutical drugs. It?s a band-aid effect. We need to break through to the root cause first. Depending on our age, there are many areas to focus on, but we must all start somewhere.
Brian concedes that ?This is why we led with Career Stress for Awareness Month and are now targeting financial stress. It?s a symptom of something far greater for everyone, however, it infects billions of people around the globe.?
Much like the preaching?s of Deepak Chopra or Mahatma Ghandi ? Brian?s message is clear. We control our own destiny. We simply need to be believe it and take responsibility for it.
To learn more about how you can become aware and begin reduce your financial stress visit http://ftrnation.com/financial-stress-1/
####
About FTRNation.com: Brian Grasso founded the FTR Nation in an effort to challenge you respectfully ignore the rules and inspire the extraordinary. To be a Freethinking Renegade is to live a life of purpose and defines success on your own terms. Visit FTRNation.com today to break through the ordinary and truly start living!
Pharma Industries, The Truth About Drug Companies (Heal Me For A Dollar)
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their FamiliesSome cool Drug Company images:
Fading ad for Greenville Ice Cream Co
Image by markemark4
A fading advertisement for Italian Vanilla ice cream by Greenville Ice Cream Company. The advertisement is located on the side of the old Taylors Drug Company location.
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT
Image by Butte-Silver Bow Public Library
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT, image taken from p 38 of Cartoons and Caricatures of Men in Montana (1907) by E.A. Thomson
Cartoons and Caricatures
of Men in Montana p 38
On cover: Just For Fun
Unique ID: mze-cart1907
Type: Book
Contributors: Artists: John C. Terry, F.P. Ellis, Alan L. Lovey, and A.H. Dutton
Date Digital: January 2011
Date Original: 1907
Source: Butte Digital Image Project at Montana Memory Project (read the book)
Library: Butte-Silver Bow Public Library in Butte, Montana, USA.
Rights Info: Public Domain. Not in Copyright. Please see Montana Memory project Copyright statement and Conditions of Use
(for more information, click here). Some rights reserved.
Attribution-Noncommercial-No Derivative Works.
More information about the href="http://cdm103401.cdmhost.com/cdm4/about.php" rel="nofollow">Montana Memory Project: Montana's Digital
Library and Archives.
More information about the Butte-Silver Bow Public Library.
Search the Butte-Silver Bow Public Library Catalog.
KATZ DRUG COMPANY SIGNAGE 1980s
Image by roberthuffstutter
.
Essential Duties and Responsibilities (include but are not limited to)
Follow department and company
manufacturing company in the Franklin County! Info for this position are:
- Assembling large materials
N165RD - Notice, No Alcohol or Drugs Permitted On Company Premises, 20" X 28"...
N165AC - Notice, No Alcohol or Drugs Permitted On Company Premises, 14" X 20"...
Davis's Drug Guide for NursesCheck out these Drug Company images:
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT
Image by Butte-Silver Bow Public Library
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT, image taken from p 38 of Cartoons and Caricatures of Men in Montana (1907) by E.A. Thomson
Cartoons and Caricatures
of Men in Montana p 38
On cover: Just For Fun
Unique ID: mze-cart1907
Type: Book
Contributors: Artists: John C. Terry, F.P. Ellis, Alan L. Lovey, and A.H. Dutton
Date Digital: January 2011
Date Original: 1907
Source: Butte Digital Image Project at Montana Memory Project (read the book)
Library: Butte-Silver Bow Public Library in Butte, Montana, USA.
Rights Info: Public Domain. Not in Copyright. Please see Montana Memory project Copyright statement and Conditions of Use
(for more information, click here). Some rights reserved.
Attribution-Noncommercial-No Derivative Works.
More information about the href="http://cdm103401.cdmhost.com/cdm4/about.php" rel="nofollow">Montana Memory Project: Montana's Digital
Library and Archives.
More information about the Butte-Silver Bow Public Library.
Search the Butte-Silver Bow Public Library Catalog.
KATZ DRUG COMPANY SIGNAGE 1980s
Image by roberthuffstutter
Drug Company eBay auctions you should keep an eye on:
Lot of 4 Ty Cobb 1953-55 Brown & Bigelow Playing Cards Casey Drug Co Chanute KS
 | .99 End Date: Saturday Aug-18-2012 11:17:15 PDT Buy It Now for only: .99 Buy It Now | Add to watch list |
ANTIQUE "OWL DRUG CO." LARGE BOTTLE - WENATCHEE, WA
 | .95 (0 Bids) End Date: Thursday Jul-19-2012 17:38:55 PDT Bid now | Add to watch list |
Stoneware Mercury Bottle - Meyer Brothers Drug Co., Saint Louis, MO
 | .95 (1 Bid) End Date: Friday Jul-20-2012 13:27:39 PDT Bid now | Add to watch list |
Check out these Drug Company images:
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT
Image by Butte-Silver Bow Public Library
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT, image taken from p 38 of Cartoons and Caricatures of Men in Montana (1907) by E.A. Thomson
Cartoons and Caricatures
of Men in Montana p 38
On cover: Just For Fun
Unique ID: mze-cart1907
Type: Book
Contributors: Artists: John C. Terry, F.P. Ellis, Alan L. Lovey, and A.H. Dutton
Date Digital: January 2011
Date Original: 1907
Source: Butte Digital Image Project at Montana Memory Project (read the book)
Library: Butte-Silver Bow Public Library in Butte, Montana, USA.
Rights Info: Public Domain. Not in Copyright. Please see Montana Memory project Copyright statement and Conditions of Use
(for more information, click here). Some rights reserved.
Attribution-Noncommercial-No Derivative Works.
More information about the Montana Memory Project: Montana's Digital
Library and Archives.
More information about the Butte-Silver Bow Public Library.
Search the Butte-Silver Bow Public Library Catalog.
Fading ad for Greenville Ice Cream Co
Image by markemark4
A fading advertisement for Italian Vanilla ice cream by Greenville Ice Cream Company. The advertisement is located on the side of the old Taylors Drug Company location.
KATZ DRUG COMPANY SIGNAGE 1980s
Image by roberthuffstutter
A new law signed into effect by President Obama this week is expected to assist researchers in developing new antibiotics for the most difficult to treat bacteria infections. Called the GAIN Act (Generating Antibiotics Incentives Now), the law provides incentives for companies to develop completely new antibiotics that can treat the most challenging bacterial infections that have become resistant to current treatments.
The law was passed to address an anticipated shortfall of new antibiotics. Few have been developed over the last decade as drug companies concluded that there were more profitable areas in which to focus their research. But the emergence of resistant organisms has alarmed infectious disease experts from around the world. The GAIN act provides financial and other incentives to bring drug makers back into the market, developing newer antibiotics to address resistant pathogens.
Radnor, PA-based PolyMedix is one company that hopes to benefit from the GAIN Act, which would give companies accelerated FDA approval, longer exclusivity and increased FDA guidance to reduce clinical study timelines. ?The GAIN Act provides companies like PolyMedix with an opportunity for priority access to the FDA for dialogue, clear clinical objectives and predictable timetables that should make antibiotic drug development more efficient and valuable for investors,? commented Nicholas Landekic, President and CEO of PolyMedix. ?This is landmark legislation that should help insure we have the drugs needed to combat todays, and tomorrows, most dangerous pathogens.?
The GAIN Act would provide incentives for companies to develop qualified infectious disease products that treat bacterial infections that have become resistant to current treatments. PolyMedix, for instance, is developing brilacidin in mid-stage studies to combat methicillin-resistant Staphylococcus aureus (MRSA). It would be the first of a new class of antibiotics called defensin-mimetics that imitates the mechanism of human immunity, exploiting a method of killing bacteria that has never led to resistance.
The new law could also encourage faster development of treatments for other bacterial infections including vancomycin-resistant Staphylococcus and enterococcus, multi-drug resistant gram-negative bacteria Acinetobacter, Klebsiella, Pseudomonas, and E. coli species, multi-drug resistant tuberculosis, and Clostridium difficile.
http://www.polymedix.com
Drug Test Friend
How To Beat A Drug Test. We Give Our Clients Full Service Support We Have Over A 99% Success Rate. Its A Top Seller. Get Involved Today To Watch Your Sales Increase. Over 200,000 Peple Tested Daily Get In The Game Today. You Will Makes Sales, Start Today!
Drug Test Friend
| | | | | | | | |
Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, reports that on June 19, 2012, the U.S. Food and Drug Administration (?FDA?) sent a warning letter to Pfizer, criticizing the company for downplaying or omitting serious Zmax side effects in a promotional brochure. Pfizer manufactures the popular antibiotic Zmax, commonly known as Zithromax or Z-Pak. According to the FDA letter, the brochure:
The FDA also noted that the company presented the limited risks and warnings in the brochure in a misleadingly minimizing format by placing Zithromax risks in obscure locations, in block paragraph format without headings or signifiers to bring to the attention of the reader.
Misleading Brochure Omits Possible Zmax Side Effects
Moreover, the FDA determined that the brochure fails to warn readers about the risk of Zithromax heart risks, such as QT prolongation, which may cause cardiac arrhythmia and torsades de pointes, potentially fatal heart problems. Another Zithromax risk left out in the brochure is a serious allergic reaction called Stevens-Johnson syndrome (?SJS?). Other misleading claims and omitted facts include the inaccurate suggestion that Zithromax is a more effective antibiotic in dosage and that the drug can treat a broader array of ailments than it is approved to treat.
The FDA ordered Pfizer to stop distributing the Zithromax brochure and required a response from the company by July 3, 2012. A Pfizer official stated that the company stopped using the brochure prior to receiving the FDA notice.
Zmax side effects have been the center of mounting concern after a study published in The New England Journal of Medicine on May 17, 2012 found an increased risk of sudden death from cardiac events in patients taking azithromycin, especially those already suffering from a cardiovascular condition.* At that time, the FDA announced that it would launch its own investigation into Zithromax risks and communicate its findings upon completion.** Pfizer conducted its own review of Zithromax risks on May 21, 2012.
The lawyers at Bernstein Liebhard LLP are currently investigating claims on behalf of individuals who experienced Zithromax side effects. Individuals who experienced Zmax side effects such as heart problems may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. To learn more about Zithromax lawsuits, watch this Zmax side effects video or visit our website, http://www.consumerinjurylawyers.com.
*nejm.org/doi/full/10.1056/NEJMoa1003833
**http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm304503.htm
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the ?Plaintiffs? Hot List,? recognizing the top plaintiffs? firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
ATTORNEY ADVERTISING. ? 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
Check out these Drug Company images:
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT
Image by Butte-Silver Bow Public Library
Louis Dreibelbis, Manager Newbro Drug Company, Butte, MT, image taken from p 38 of Cartoons and Caricatures of Men in Montana (1907) by E.A. Thomson
Cartoons and Caricatures
of Men in Montana p 38
On cover: Just For Fun
Unique ID: mze-cart1907
Type: Book
Contributors: Artists: John C. Terry, F.P. Ellis, Alan L. Lovey, and A.H. Dutton
Date Digital: January 2011
Date Original: 1907
Source: Butte Digital Image Project at Montana Memory Project (read the book)
Library: Butte-Silver Bow Public Library in Butte, Montana, USA.
Rights Info: Public Domain. Not in Copyright. Please see Montana Memory project Copyright statement and Conditions of Use
(for more information, click here). Some rights reserved.
Attribution-Noncommercial-No Derivative Works.
More information about the Montana Memory Project: Montana's Digital
Library and Archives.
More information about the Butte-Silver Bow Public Library.
Search the Butte-Silver Bow Public Library Catalog.
KATZ DRUG COMPANY SIGNAGE 1980s
Image by roberthuffstutter
Drug Company on eBay:
vintage medicine Wells' Tablets tin 50c size National Drug Co. Washington D.C.
 | .00 End Date: Thursday Aug-2-2012 6:57:36 PDT Buy It Now for only: .00 Buy It Now | Add to watch list |
Cobalt Blue Bromo-Seltzer Emerson Drug Co. Glass Bottle
 | .00 (0 Bids) End Date: Wednesday Jul-4-2012 10:02:02 PDT Buy It Now for only: .00 Buy It Now | Bid now | Add to watch list |
Marijuana is a mixture of the crushed leaves and flowering tops of the hemp plant (Cannabis sativa). The plant contains a substance called THC (tetrahydrocannabinal) that has a combination of psychoactive properties which defy simple categorization. It produces euphoria and release from inhibition much like the depressant alcohol; the relaxation or even fatigue of a sedative; and hypnotic, sensory, and perceptual distortions like a mild hallucinogen (which ordinarily increases wakefulness). This is why marijuana and other cannabis drugs are treated as a unique category of psychoactive substance in the latest revision of the Diagnostic and Statistical Manual of Mental Disorders, or DSM III (1980). The various forms of cannabis�� differ chiefly in their concentration of THC. Of the natural forms of cannabis, marijuana is the least potent, and hashish (pure plant resin) the most potent. Recently an almost pure form of THC has been artificially synthesized in the laboratory.
Cannabis is most frequently taken by smoking it in a cigarette or pipe. It can also be eaten (Alice B. Toklas, a friend of the poet Gertrude Stein, is said to have baked delicious marijuana brownies). At low dosages, most users quickly develop a feeling of relaxed euphoria. Some become more talkative, while others become quiet and contemplative. Many describe their perceptions and sensory experiences as intensified and unusual. Previously�� unnoticed colors and sounds become vivid and important. Space and forms may appear distorted, and time slows. However, while many people feel only pleasant or interesting effects, others become anxious and irritable. The particular pattern of one's reactions depends a great deal on the particular situation and the behavior of those who are nearby.
There are physical symptoms as well. The eyes redden as blood vessels dilate, the mouth dries as saliva flow is inhibited, and the heart beats faster; appetite often increases.
As more THC enters the bloodstream, the user feels more and more drowsy. Speech may become slurred and thinking distorted. Things may seem hysterically funny and inspire long spells of giggling. Finally, the user falls into a deep sleep.
For many centuries, cannabis was used in Asia as an anesthetic and medication for maladies ranging from insomnia to rheumatism. In the mid-nineteenth century, Western European doctors began to prescribe it for neuralgia, menstrual pain, and migraine headaches. In the early twentieth�� century, its medical use was widely promoted in the United States by the drug company Parke-Davis. By the 1930s, however, doctors were prescribing such other drugs as morphine, aspirin, and barbiturates instead.
Marijuana began to be used simply for pleasure and was distributed illegally.
This period was marked by progressively harsher antidrug laws, and by 1937, marijuana, incongruously lumped with opium and heroin, was completely outlawed. During the 1960s marijuana use underwent a resurgence, with growing recognition that the harsh legal penalties seemed inconsistent with its apparent low level of danger, The National Survey of Drug Abuse (1979) reported that during 1979 more than 26 million Amercans icons used cannabis at least once, including 31 percent of adolescents under�� 18 (10 percent of all high-school seniors), 68 percent of individuals between 18 and 25, and 20 percent of those over 26. It is clear that earlier efforts to characterize cannabis as a "killer weed'' were counterproductive exaggerations. Concerning its safety, however, real doubts still remain. Some evidence suggests that it is addictive.
Chronic users may develop tolerance (Nowland & Cohen, 1977) and experience� withdrawal symptoms such as loss of appetite, running nose, diarrhea, and sweating (Jones, 1977). Also, the potency of illegally obtained cannabis has increased, and there are more instances of accidents related to cannabis intoxication (Marijuana Research Findings, 1980). Longer-term dangers may include susceptibility to lung disease (Tashkin, Calvarese, & Simmons, 1978) and reduced fertility (Hembree, Nabias, & Huang, 1979).
Did you like this article? You can write articles like this and make money from it. It is free to join and you can make money online as soon as you sign-up. Click on the link to Sign-up with Bukisa.com and starting making some good money on the internet.
More Content on the Web by Spill Guy:
Written by Spill Guy
